Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 103: 2084-2094, 2007. First published September 27, 2007; doi:10.1152/japplphysiol.00695.2007
8750-7587/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
103/6/2084    most recent
00695.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Klinger, J. R.
Right arrow Articles by Harrington, E. O.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klinger, J. R.
Right arrow Articles by Harrington, E. O.

Rottlerin causes pulmonary edema in vivo: a possible role for PKC{delta}

James R. Klinger,1 Josh D. Murray,1 Brian Casserly,1 Diego F. Alvarez,2 Judy A. King,2 Steven S. An,3 Gaurav Choudhary,1 Akua N. Owusu-Sarfo,1 Rod Warburton,1 and Elizabeth O. Harrington1

1Vascular Research Laboratory, Providence Veterans Affairs Medical Center, and Department of Medicine, Brown Medical School, Providence, Rhode Island; 2Center for Lung Biology, University of South Alabama College of Medicine, Mobile, Alabama; and 3Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland

Submitted 28 June 2007 ; accepted in final form 16 September 2007

In the present study, we assessed the effects of chemical inhibitors shown to be selective for protein kinase C (PKC) isoforms on lung barrier function both in vitro and in vivo. Rottlerin, a purported inhibitor of PKC{delta}, but not other chemical inhibitors, dose dependently promoted barrier dysfunction in lung endothelial cells in vitro. This barrier dysfunction correlated with structural changes in focal adhesions and stress fibers, which were consistent with functional changes in cell stiffness. To determine whether the effects noted in vitro correlated with changes in intact lungs, we tested the effects of rottlerin in the formation of pulmonary edema in rats using both ex vivo and in vivo models. Isolated, perfused lungs demonstrated a significant increase in filtration coefficients on exposure to rottlerin, compared with vehicle-treated lungs, an effect that correlated with increased extravasation of Evan's blue dye (EBD)-conjugated albumin. Additionally, compared with vehicle, the ratio of the wet lung weights to dry lung weights was significantly greater on exposure of animals to rottlerin; rottlerin also produced a dose-dependent increase in EBD extravasation into the lungs. These effects on lung edema occurred without any increase in right ventricular pressures. Microscopic assessment of edema in the ex vivo lungs demonstrated perivascular cuffing, with no evidence of septal capillary leak, in rottlerin-exposed lungs. Taken together, rottlerin increases barrier dysfunction in pulmonary endothelial cell monolayers and causes pulmonary edema in rats; results suggestive of an important role for PKC{delta} in maintaining lung endothelial barrier function.

endothelium; lung; permeability; protein kinase C



Address for reprint requests and other correspondence: E. O. Harrington, Providence VA Medical Center, Research Services 151, 830 Chalkstone Ave., Providence, RI 02908 (e-mail: Elizabeth_Harrington{at}brown.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.